Sort
40,608 grants matching “prostate cancer”
Targeted Discovery of Marine-derived Anticancer Leads
$1,100,018Phil Crews · University Of California Santa Cruz · U19 · FY2009 · CA
IMAGE GUIDED THERAPY (MR Guided Therapy)
$1,099,994Ferenc A Jolesz · Brigham And Women'S Hospital · P01 · FY2007 · CA
MCTP: Mathematics Mentoring Partnership Between Arizona State University and the Maricopa County Community College District
$1,099,808Eric J Kostelich · Arizona State University · · FY2012 · MPS
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,099,568Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2019 · CA
PROSTATE, LUNG, COLORECTAL &OVARIAN (PLCO) CANCER
$1,099,130Washington University · N01 · FY2000 · CN
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,099,106Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Clinical Nursing and Data Management Core
$1,098,267William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2010 · CA
Novel Targets for Vaccine Therapy
$1,097,667Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,097,545Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2020 · CA
Signal Processing And Instrumentation Section
$1,097,447Thomas J Pohida · Center For Information Technology · ZIA · FY2015 · CT
INHIBITORS OF FATTY ACID SYNTHASE FOR PROSTATE CANCER
$1,096,588Wake Forest University Health Sciences · · FY2009 · Department of Defense
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
$1,096,389Everette C Burdette · Acoustic Medsystems, Inc. · R44 · FY2011 · CA
TARGETING WNT5A-MEDIATED THERAPY RESISTANCE MECHANISMS AND TUMOR GENOMIC HETEROGENEITY IN LETHAL BONE METASTATIC PROSTATE CANCER
$1,096,167University Of California, San Diego · · FY2019 · Defense Health Agency
PROSPECTIVE PERSONAL BIOMARKERS OF LATE-STAGE AND LETHAL PROSTATE CANCER IN AFRICAN AMERICANS
$1,095,964Public Health Institute · · FY2021 · Defense Health Agency
Transgenic Models for Prostate and Breast Cancer
$1,095,844Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Modeling prostate cancer control: prevention, screening, treatment, followup care
$1,095,792Ruth D Etzioni · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA
Investigation of Germ-line Genetic Variation and Susceptibility to Cancer and it
$1,095,659Stephen J Chanock · Clinical Sciences · Z01 · FY2007 · CA
Molecular Cytogenetics of Solid Tumors
$1,095,529Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
RESEARCH CAPACITY CORE
$1,094,924Geou-Yarh Liou · Clark Atlanta University · U54 · FY2024 · MD
COBRE in Lipidomics and Pathobiology
$1,094,825Besim Ogretmen · Medical University Of South Carolina · P30 · FY2014 · GM
COBRE in Lipidomics and Pathobiology
$1,094,825Besim Ogretmen · Medical University Of South Carolina · P30 · FY2012 · GM
COBRE in Lipidomics and Pathobiology
$1,094,825Besim Ogretmen · Medical University Of South Carolina · P30 · FY2016 · GM
COBRE in Lipidomics and Pathobiology
$1,094,825Besim Ogretmen · Medical University Of South Carolina · P30 · FY2015 · GM
Cell and Cancer Biology Branch Confocal Microscopy Core
$1,094,766Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
TUMOR SUPPRESSOR RARRES1/TIG1 IN PROSTATE CANCER BIOMARKERS TO THERAPRUTIC TARGET
$1,094,672University Of The District Of Columbia · · FY2012 · Department of Defense